Tag: Risk Matrix

  • COVID Showing Stable and Declining Global Rates

    Key Points: In today’s Recommendations for Industry, we discuss COVID-19 trends stabilizing and declining. Read more below. The CDC released research done on post-COVID conditions among adult COVID-19 survivors aged 18-64 and younger than 65, here are some results: Another figure shows additional areas of the body that were included in the research conducted. Independent…

  • Levels Increasing, but Significantly Lower than Early 2022

    Key Points: In today’s Recommendations for Industry, we discuss the trends of COVID based on TAG’s weekly matrix and the CDC community levels mapping. Read more below. Four global regions around the world have seen a rise in COVID-19 cases, including in the Eastern Mediterranean region, Western Pacific, The Americas, and the African region. The…

  • COVID Variants Continue Impacting NE U.S.

    Key Points: In today’s Recommendations for Industry, we discuss the latest COVID transmissibility data from both TAG’s matrix and CDC’s mapping. Read more below. Today, North Korea imposed a nationwide lockdown as it’s acknowledging its first confirmed COVID-19 outbreak (AP News).  COVID-19 cases continue to rise in Africa and the Americas. In fact, “16 major…

  • Weekly COVID Matrix Shows “Smoldering” of Cases

    Key Points: In today’s Recommendations for Industry, we discuss the slight increase in cases around the U.S. Read more below. The FDA is warning consumers of counterfeit over-the-counter COVID-19 diagnostics (at-home) tests. Find out more about the tests that are now considered counterfeit. As consumers also have been wondering about the shelf-life/expiration of their at-home…

  • Number of Factors Keeping U.S. COVID Rates Low

    Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and the “gentle swell” of COVID in the U.S. Read more below. CDC: 58% of Americans have had COVID-19. New COVID-19 seroprevalence data from CDC show that the Omicron surge infected a huge swath of Americans, with overall seroprevalence rising from 33.5% in December of…

  • CDC Map Showing Low COVID Levels Across 94% of U.S.

    Key Points: In today’s Recommendations for Industry, we discuss low COVID levels across much of the U.S. with some regional levels of BA.2.12. Read more below. DOJ appeals federal ruling on transportation mask mandate. The Justice Department on Wednesday appealed a ruling by a federal judge that struck down the mask mandate for mass transportation,…

  • COVID Case Nudges No Cause for Behavior Change

    Key Points: In today’s Recommendations for Industry, we discuss the current status of COVID and the conflicting news.  Read more below. The CDC has extended mask mandates on planes through May 3 (NYT). The FDA has “granted an extension for the shelf life of the authorized” Pfizer vaccine; vials can be stored, frozen, at ultra-low…

  • Cases decreasing: Maintain Course

    Key Points: In today’s Recommendations for Industry, we discuss decreasing COVID cases and advice to maintain the course. Read more below. A recent Duke University study has found that US healthcare workers “had similar rates of potential moral injury – a type of trauma-induced wound to the psyche – as military combat veterans” leading to…

  • U.S. Seeing Only a Blip in Cases Despite BA.2 Dominance

    Key Points: In today’s Recommendations for Industry, we discuss the “blip” in U.S. COVID cases, despite the fact that BA.2 has become the dominant variant. Read more below. FDA Authorizes Second Booster for Older and Immunocompromised Individuals. FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people…

  • Trends Indicate Slight Nudge (not surge) in U.S. COVID Cases

    Key Points: In today’s Recommendations for Industry, we discuss TAG’s interpretation of COVID trends being seen in TAG’s matrix and other news indicating a “nudge” – not a surge – in the US. Read more below. Weekly WHO Update: Global COVID-19 cases climb for second week in a row. Led mainly by surges in Asian…